AWM
EDIT icon

Ameliora Wealth Management’s Editas Medicine EDIT Stock Holding History

Ameliora Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-500
Closed -$1.1K – 229
2025
Q2 		$1.1K Hold
500
– – ﹤0.01% 210
2025
Q1 		$580 Hold
500
– – ﹤0.01% 236
2024
Q4 		$635 Hold
500
– – ﹤0.01% 235
2024
Q3 		$1.71K Hold
500
– – ﹤0.01% 157
2024
Q2 		$2.33K Hold
500
– – ﹤0.01% 175
2024
Q1 		$3.71K Hold
500
– – ﹤0.01% 187
2023
Q4 		$5.07K Hold
500
– – ﹤0.01% 174
2023
Q3 		$3.9K Hold
500
– – ﹤0.01% 205
2023
Q2 		$4.12K Hold
500
– – ﹤0.01% 184
2023
Q1 		$3.63K Hold
500
– – ﹤0.01% 199
2022
Q4 		$4.43K Hold
500
– – ﹤0.01% 213
2022
Q3 		$5K Buy
+500
New +$7.79K ﹤0.01% 205

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameliora Wealth Management's EDIT Position: Q3 2025 in Review

Ameliora Wealth Management sold out of Editas Medicine (EDIT) in Q3 2025, closing a stake of 500 shares — an estimated $1.1K sold.

Ameliora Wealth Management first reported a position in EDIT in Q3 2022 and held it in 12 quarters. The position peaked at $5.07K in Q4 2023. 193 funds tracked by Wall St. Rank hold EDIT as of Q3 2025.

  • Ameliora Wealth Management reported no remaining Editas Medicine position as of Q3 2025 after selling out during the quarter.
  • Ameliora Wealth Management sold 500 Editas Medicine shares in Q3 2025, an estimated $1.1K.
  • Ameliora Wealth Management first reported a position in Editas Medicine in Q3 2022 and held it in 12 quarters.
  • Ameliora Wealth Management's Editas Medicine position peaked at $5.07K in Q4 2023.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2025.

Based on Ameliora Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.